In meeting with RFK Jr., CEO of Tylenol maker stresses there is no clear link between medication and autism, WSJ reports

The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, met with US Health and Human Services Secretary Robert F. Kennedy Jr. privately this week in an attempt to dissuade him from including the drug as a potential cause of autism in an upcoming report, the Wall Street Journal reported Friday.

​ The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, met with US Health and Human Services Secretary Robert F. Kennedy Jr. privately this week in an attempt to dissuade him from including the drug as a potential cause of autism in an upcoming report, the Wall Street Journal reported Friday. Read More Breaking News, Latest News and Videos | CNN